Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients (AIR)

This study has been completed.
Information provided by (Responsible Party):
Kreton Mavromatis, MD, FACC, Emory University Identifier:
First received: September 19, 2006
Last updated: September 11, 2013
Last verified: September 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2009
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)